ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,062.21
-5.91%
S&P 500
5,062.03
-1.06%
Dow Jones
37,940.36
-1.16%
US Dollar vs Yen
157.7445
0.91%
Brent Oil
86.065
-1.40%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) ニュース

ALVO Alvontech

14.59
0.37 (2.60%)
最終更新日： 04:28:19
15分遅延
名称 銘柄コード 市場 種別
Alvontech ALVO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.37 2.60% 14.59 04:28:19
始値 安値 高値 終値 前日終値
14.67 14.46 14.76 14.22
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3017:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
2024/4/2417:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
2024/4/1919:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
2024/4/1706:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
2024/4/1706:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
2024/4/0320:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
2024/3/2305:15GLOBEAlvotech Announces Increase in Number of Own Shares
2024/3/2105:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
2024/3/2020:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
2024/3/0606:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
2024/3/0106:05GLOBEAlvotech Appoints Interim Chief Quality Officer
2024/2/2618:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
2024/2/2410:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
2024/2/2410:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
2024/2/1520:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
2024/1/2918:00GLOBEAlvotech Announces Positive Top-Line Results from a..
2024/1/2002:31DJNAlvotech Shares Climb After FDA Concludes Facility..
2024/1/2001:30GLOBEAlvotech Provides Update on Status of Biologics License..
2024/1/1017:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
2024/1/0317:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
2023/11/2918:00GLOBEAlvotech Announces Positive Top-Line Results from a..
2023/11/2906:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
2023/11/2122:00GLOBEAlvotech to Report Financial Results for the First Nine..
2023/11/1421:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
2023/11/1023:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
2023/11/0722:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
2023/10/1217:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
2023/10/0321:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
2023/10/0318:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
2023/9/2517:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
2023/9/2017:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
2023/9/0522:30GLOBEAlvotech Announces Changes to the Leadership Team
2023/8/3105:15GLOBEAlvotech Reports Financial Results for First Six Months of..
2023/8/2918:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
2023/8/2222:15GLOBEAlvotech to Report Financial Results for the First Half of..
2023/7/3117:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
2023/7/2417:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
2023/7/0322:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
2023/6/2909:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
2023/6/2908:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
2023/6/1220:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
2023/6/1216:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
2023/5/3118:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
2023/5/2418:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
2023/5/1918:00GLOBEAlvotech Reports Financial Results for First three Months of..
2023/5/1718:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
2023/5/1518:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
2023/5/1018:00GLOBEAlvotech enters into commercialization agreement with..
2023/5/0418:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
2023/5/0322:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

最近閲覧した銘柄

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有